Robert Peter Gale

45.6k total citations · 6 hit papers
609 papers, 24.0k citations indexed

About

Robert Peter Gale is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Robert Peter Gale has authored 609 papers receiving a total of 24.0k indexed citations (citations by other indexed papers that have themselves been cited), including 392 papers in Hematology, 185 papers in Genetics and 112 papers in Oncology. Recurrent topics in Robert Peter Gale's work include Hematopoietic Stem Cell Transplantation (197 papers), Acute Myeloid Leukemia Research (161 papers) and Chronic Myeloid Leukemia Treatments (101 papers). Robert Peter Gale is often cited by papers focused on Hematopoietic Stem Cell Transplantation (197 papers), Acute Myeloid Leukemia Research (161 papers) and Chronic Myeloid Leukemia Treatments (101 papers). Robert Peter Gale collaborates with scholars based in United States, United Kingdom and China. Robert Peter Gale's co-authors include Eli Canaani, Richard E. Champlin, Mary M. Horowitz, Emma Shtivelman, Winston G. Ho, Drew J. Winston, Hillard M. Lazarus, Yehuda Shavit, Philip A. Rowlings and Jacob Zighelboim and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Robert Peter Gale

579 papers receiving 22.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fused transcript of abl and bcr genes in chronic myelogenous leukaemia

1985 1.3k citations Robert Peter Gale et al. profile →
Outcomes after Transplantation of Cord Blood or Bone Marrow from Unrelated Donors in Adults with Leukemia

2004 783 citations Mary Eapen, Robert Peter Gale et al. profile →
Bone Marrow Transplantation for Chronic Myelogenous Leukemia in Chronic Phase

1988 692 citations John M. Goldman, Robert Peter Gale et al. profile →
Solid Cancers after Bone Marrow Transplantation

1997 677 citations Philip A. Rowlings, Gèrard Socié et al. profile →
Opioid Peptides Mediate the Suppressive Effect of Stress on Natural Killer Cell Cytotoxicity

1984 496 citations Yehuda Shavit, Robert Peter Gale et al. profile →
Infectious Complications of Human Bone Marrow Transplantation

1979 337 citations Robert Peter Gale et al. profile →

Peers

Countries citing papers authored by Robert Peter Gale

Since Specialization

Citations

This map shows the geographic impact of Robert Peter Gale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Peter Gale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Peter Gale more than expected).

Fields of papers citing papers by Robert Peter Gale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Peter Gale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Peter Gale. The network helps show where Robert Peter Gale may publish in the future.

Co-authorship network of co-authors of Robert Peter Gale

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Peter Gale. A scholar is included among the top collaborators of Robert Peter Gale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Peter Gale. Robert Peter Gale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A New Targeted Therapy Strategy for Lymphoma 2025 ·MedComm ·Robert Peter Gale	1
2	Factors Affecting the Receptiveness of Chinese Internists and Surgeons Toward Artificial Intelligence–Driven Drug Prescription: Protocol for a Systematic Survey Study 2025 ·JMIR Research Protocols ·Qiujin Shen, (unknown), (unknown), Yu Hu, (unknown), (unknown), (unknown), (unknown), Robert Peter Gale, (unknown), Junren Chen	0
3	Dialog between mantle cell lymphoma cells and lymphoma-associated macrophages underlies ibrutinib resistance 2024 ·Journal of Advanced Research ·Xiaoqing Sun, Caiqin Wang, (unknown), Jing Li, (unknown), Xianqiu Wu, Peng Sun, Yu Wang, Jiajia Huang, Robert Peter Gale, Zhiming Li	3
4	Immune therapies of B-cell acute lymphoblastic leukaemia in children and adults 2024 ·Critical Reviews in Oncology/Hematology ·(unknown), Gabriel Ghiaur, (unknown), Ciprian Tomuleasa, Robert Peter Gale	7
5	Imatinib dose reduction after major molecular response in chronic‐phase chronic myeloid leukemia 2024 ·Cancer ·(unknown), Xiaoshuai Zhang, Yijing Zhao, (unknown), Yong Guo, Robert Peter Gale, (unknown), Qian Jiang	2
6	Switching from salvage chemotherapy to immunotherapy in adult B-cell acute lymphoblastic leukemia 2023 ·Blood Reviews ·(unknown), (unknown), Gabriel Ghiaur, Stefan O. Ciurea, Dieter Hoelzer, Ciprian Tomuleasa, Robert Peter Gale	9
7	Therapy of childhood acute lymphoblastic leukemia in resource-poor geospaces 2023 ·Frontiers in Oncology ·(unknown), Robert Peter Gale, (unknown), (unknown), (unknown), Wendy Stock, Iván Murrieta-Álvarez, Juan Carlos Olivares‐Gazca, Guillermo J. Ruiz‐Delgado, Rafaël Fonseca, Guillermo J. Ruíz‐Argüelles	1
8	What causes aplastic anaemia? 2023 ·Leukemia ·Robert Peter Gale, W Hinterberger, Neal S. Young, Andrew R. Gennery, Christopher C. Dvorak, Kyle Hebert, (unknown), Larisa Broglie, Mary Eapen	5
9	Predictive scoring systems for molecular responses in persons with chronic phase chronic myeloid leukemia receiving initial imatinib therapy 2022 ·Leukemia ·Xiaoshuai Zhang, Robert Peter Gale, (unknown), Mengyu Zhang, Xiao‐Jun Huang, Qian Jiang	4
10	HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusions 2021 ·Leukemia ·Elspeth A. Bruford, Cristina R. Antonescu, Andrew J. Carroll, Arul M. Chinnaiyan, Ian A. Cree, Nicholas C.P. Cross, Raymond Dalgleish, Robert Peter Gale, Christine J. Harrison, (unknown), Jean‐Loup Huret, Bertil Johansson, Michelle Le Beau, Cristina Mecucci, Fredrik Mertens, Roel G.W. Verhaak, Felix Mitelman	47
11	JAK-inhibitors for coronavirus disease-2019 (COVID-19): a meta-analysis 2021 ·Leukemia ·Chongxiang Chen, Jiaojiao Wang, Huan Li, (unknown), Robert Peter Gale, Yang Liang	64
12	Chronic myeloid leukemia stem cells 2019 ·Leukemia ·Mohammad Houshmand, Giorgia Simonetti, Paola Circosta, Valentina Gaidano, Alessandro Cignetti, Giovanni Martinelli, Giuseppe Saglio, Robert Peter Gale	131
13	Freezing the graft is not necessary for autotransplants for plasma cell myeloma and lymphomas 2018 ·Bone Marrow Transplantation ·Amado Karduss, Robert Peter Gale, Cesar Homero Gutiérrez‐Aguirre, (unknown), Iván Murrieta-Álvarez, (unknown), Guillermo J. Ruiz‐Delgado, (unknown), Gregorio Jaimovich, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), David Gómez‐Almaguer, Guillermo J. Ruíz‐Argüelles	23
14	Unique features of primary myelofibrosis in Chinese 2012 ·Blood ·Zefeng Xu, Robert Peter Gale, Yue Zhang, Tiejun Qin, (unknown), Peihong Zhang, Tianjiao Zhang, Liu Liu, Shiqiang Qu, Zhijian Xiao	22
15	Effect of Age on Outcome of Reduced-Intensity Hematopoietic Cell Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission or With Myelodysplastic Syndrome 2010 ·Journal of Clinical Oncology ·Brian McClune, Daniel J. Weisdorf, Tanya L. Pedersen, Gisela Tunes da Silva, Martin S. Tallman, Jorge Sierra, John F. DiPersio, Armand Keating, Robert Peter Gale, Biju George, Vikas Gupta, Theresa Hahn, Luis Isola, Madan Jagasia, Hillard M. Lazarus, David I. Marks, Richard T. Maziarz, Edmund K. Waller, Christopher Bredeson, Sergio Giralt	338
16	Immune therapy of chronic myelogenous leukemia 2005 ·Leukemia Research ·Robert Peter Gale, Mary M. Horowitz, Moshe Talpaz, David A. Scheinberg, Jeffrey J. Molldrem, Zihai Li, Michele Baccarani, John M. Goldman, S Tura	1
17	Bone Marrow Transplantation—1994: A Report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry 1994 ·Journal of Hematotherapy ·(unknown), M. Horowitz, Philip A. Rowlings, Mei‐Jie Zhang, Melodee Nugent, Jakob Passweg, Jamés O. Armitage, Robert Peter Gale, Mortimer M. Bortin	18
18	Cancer after bone marrow transplantation. 1992 ·Site cant be reached ·(unknown), (unknown), Thomas Duell, Gèrard Socié, Edward M. Schaeffer, Ernst Holler, (unknown), Mary M. Horowitz, Robert Peter Gale, (unknown)	3
19	Advances and controversies in thalassemia therapy : bone marrow transplantation and other approaches : proceedings of an International Symposium on Bone Marrow Transplantation and Related Problems, held in Urbino, Italy, September 22-25, 1988 1989 ·(unknown), C. Dean Buckner, Robert Peter Gale, Guido Lucarelli	0
20	Naltrexone sensitive suppression of the immune systems natural killer cells by morphine 1984 ·The Society for Neuroscience Abstracts ·Yehuda Shavit, G.W. Terman, Fredricka C. Martin, Robert Peter Gale, J.C. Liebeskind	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact